Skip to main content
Top
Published in: Internal and Emergency Medicine 4/2020

01-06-2020 | CE - LETTER TO THE EDITOR

Endoplasmic reticulum aminopeptidase protein 1 and Behçet’s syndrome

Authors: Beuy Joob, Viroj Wiwanitkit

Published in: Internal and Emergency Medicine | Issue 4/2020

Login to get access

Excerpt

Dear Editor, we read the publication on “Distribution of rs17482078 and rs27044 ERAP1 polymorphisms in a group of Italian Behçet’s syndrome (BS) patients: a preliminary case–control study” with a great interest [1]. Padula et al. concluded that “our data show a stronger association of rs17482078 with BS compared to rs27044 by means of case–control genetic analysis and bioinformatics prediction of protein structure change [1]”. We would like to share ideas and discuss on the effect of the studied genetic variants. Indeed, this observation is explainable by the molecular change. Regarding rs17482078 (NG_027839.1:g.35983G>A) and rs27044 (NG_027839.1:g.35997C>G), the main change is at a nucleic acid in each variant. Based on the molecular weight alteration calculation as mentioned in the previous literatures [24], the change in rs17482078 and rs27044 is equal to − 16 and + 40.02 g/Mol. Therefore, the expression process in rs27044 is more difficult and the stronger association with BS can be expected in rs17482078. This pathophysiological process is explainable in the same way as those described in clinical association between genetic variants and other medical disorder [24]. …
Literature
1.
go back to reference Padula MC, Leccese P, Pellizzieri E, Padula AA, Gilio M, Carbone T, Lascaro N, Tramontano G, Martelli G, D’Angelo S (2019) Distribution of rs17482078 and rs27044 ERAP1 polymorphisms in a group of Italian Behçet’s syndrome patients: a preliminary case–control study. Int Emerg Med 14:713–718CrossRef Padula MC, Leccese P, Pellizzieri E, Padula AA, Gilio M, Carbone T, Lascaro N, Tramontano G, Martelli G, D’Angelo S (2019) Distribution of rs17482078 and rs27044 ERAP1 polymorphisms in a group of Italian Behçet’s syndrome patients: a preliminary case–control study. Int Emerg Med 14:713–718CrossRef
2.
go back to reference Yasri S, Wiwanitkit V (2018) Caspase recruitment domain-containing protein 8 rs2043211 polymorphism and cardiovascular disease susceptibility. Anatol J Cardiol 20(6):368PubMedCentral Yasri S, Wiwanitkit V (2018) Caspase recruitment domain-containing protein 8 rs2043211 polymorphism and cardiovascular disease susceptibility. Anatol J Cardiol 20(6):368PubMedCentral
3.
go back to reference Yasri S, Wiwanitkit V (2018) Having rs1042636C677T calcium-sensing receptor polymorphism: increased or decreased risk for nephrolithiasis? Saudi J Kidney Dis Transpl 29(3):743–744CrossRef Yasri S, Wiwanitkit V (2018) Having rs1042636C677T calcium-sensing receptor polymorphism: increased or decreased risk for nephrolithiasis? Saudi J Kidney Dis Transpl 29(3):743–744CrossRef
4.
go back to reference Joob B, Wiwanitkit V (2016) SD11B1 rs846908 polymorphisms and tacrolimus concentrations: quantum chemical analysis and implication in patients with renal transplantation. J Nephropharmacol 6(1):19–20PubMedCentral Joob B, Wiwanitkit V (2016) SD11B1 rs846908 polymorphisms and tacrolimus concentrations: quantum chemical analysis and implication in patients with renal transplantation. J Nephropharmacol 6(1):19–20PubMedCentral
5.
go back to reference Krause I, Weinberger A (2008) Behçet’s disease. Curr Opin Rheumatol 20(1):82–87CrossRef Krause I, Weinberger A (2008) Behçet’s disease. Curr Opin Rheumatol 20(1):82–87CrossRef
Metadata
Title
Endoplasmic reticulum aminopeptidase protein 1 and Behçet’s syndrome
Authors
Beuy Joob
Viroj Wiwanitkit
Publication date
01-06-2020
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 4/2020
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-019-02181-6

Other articles of this Issue 4/2020

Internal and Emergency Medicine 4/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.